179 Million Europeans are currently living with brain disorders. This is to steady increase, as the population ages.
At some point of their life, one in three Europeans will live with a brain disease – neurological and mental alike. As a result, the estimations are that brain disorders account for up to 45% of total healthcare budgets. Therefore, this burden is expected to grow.
Despite the prevalence of brain disorders in Europe, a wide range of mental and neurological conditions has currently no disease-modifying treatment or cure. Developing treatments can significantly improve the lives of those living with brain disorders, but it is extremely challenging.
Compared to other disease areas, multiple factors hinder the pace of innovation in this field, including the complexity of the brain itself. As a result, brain treatments remain insufficient. In addition, research is disproportionally underfunded compared to other disease areas.
In conclusion, we believe enhanced multi-stakeholder engagement in the brain ecosystem is needed to foster dialogue, exchange knowledge, accelerate investment in research and innovation, facilitate business development and showcase on-going work.